Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Health Care Reform Highlights In 2008

This article was originally published in PharmAsia News

Executive Summary

China's central government will allocate 83.2 billion yuan to support the reform and development of health care, according to a working report at the recent National People's Congress session. The Ministry of Health has identified four key areas in 2008 for implementing the reform: 1) accelerating the health insurance push to cover urban and rural population; 2) setting up a proper public health service system; 3) building a structure for medical treatment and health services; and 4) establishing a national system that ensures basic drug supply and safety. China will also expand its immunity program to cover 15 diseases, with free treatment for major illnesses such as AIDS and tuberculosis. (Click here for more - Chinese Language)

You may also be interested in...



Warning Letter Close-Outs – October 2020

The US FDA issued only one device-related close-out letter in October.

Compounding Pharmacies Sue FDA For Conflating Out-Of-State Dispensing And Distribution In MOU

Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.

What COVID Spotlight Means For Pharma – In Their Own Words

Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem. 

UsernamePublicRestriction

Register

LL1133229

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel